GKGrazyna Kostka

Grazyna Kostka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grazyna Kostka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2014
      • Vol. 65  (3) , 199-203

    The effect of phenobarbital on gene expression levels of p53 and Dnmt1 in the liver of Wistar rats.

    by Katarzyna Urbanek-Olejnik, Monika Liszewska, Grażyna Kostka

    Our previous studies have shown that short-term treatment with phenobarbital (PB) resulted in cytosine methylation of CpG sites on the p53 gene promoter in male Wistar rats' liver. Furthermore, PB induced DNA-methyltransferases (DNMTs) activity was also demonstrated; being the enzymes that catalyze methyl group transfer to cytosine in CpG dinucleotides. Since DNA methylation is involved in regulating gene transcription and that DNMT1 is implicated in regulating DNA methylation, this study assessed whether PB-induced hypermethylation of the p53 promoter region was associated with an altered expression of p53 and Dnmt1 genes. Male Wistar rats received PB in three daily oral doses (at 24-h intervals) of 92,8 mg/kg b.w. x day-1. Levels of mRNA for p53 and Dnmt1 and levels of relevant proteins were respectively examined by Real-Time PCR and Western blot analysis. Gene expression analysis revealed that exposure of Wistar rats to PB caused statistically significant alternations in the expression of tested genes. We found that both mRNA and protein expression of p53 was down-regulated, whereas expression of Dnmt1 (both mRNA and protein) was up-regulated after PB treatment. Suppression of p53 mRNA and protein expression, which is probably a result of epigenetic changes, (in particular aberrant p53 promoter hypermethylation), can be associated with tumour promoting activity of phenobarbital.

  • Changes of c-Myc and DNMT1 mRNA and protein levels in the rat livers induced by dibutyl phthalate treatment

    by Katarzyna Urbanek-Olejnik, Monika Liszewska, Alicja Winczura, Grażyna Kostka

    We investigated the relationship between dibutyl phthalate (DBP)-induced hypomethylation of the c-Myc promoter region (as evident in our early study) and the expression of c-Myc and DNMT1 genes (at messenger RNA (mRNA) and protein level) in the rat liver. Male Wistar rats received DBP in 1, 3, or 14 daily doses of 1800 mg kg−1 body weight. Levels of DNMT1, c-Myc mRNA, and proteins were detected using real-time polymerase chain reaction and Western blot analysis, respectively. Our findings indicate that DBP caused an increase in mRNA levels of c-Myc at all time points. The results showed that protein levels of c-Myc in rat liver also increased significantly by DBP treatment, which were more pronounced at last time point (after 14 doses). Furthermore, overexpression of DNMT1gene have been found after one dose of DBP, which was confirmed at the protein level by Western blot analysis. Reduced levels of DNMT1mRNA and proteins (3 and 14 doses) were coordinated with depletion DNA synthesis (reported previously). Based on our previous results and those presented here, the following conclusion could be drawn: (1) DBP exerted biological activity through epigenetic modulation of c-Myc gene expression; (2) it seems possible that DBP-induced active demethylation of c-Myc gene through mechanism(s) linked to generation of reactive oxygen species by activated c-Myc; and (3) control of DNA replication was not directly dependent on c-Myc transcriptional activity and we attribute this finding to DNMT1gene expression which was tightly coordinated with DNA synthesis.


    • 1 January 2012
      • Vol. 63  (4) , 425-32

    [The effect of dibutyl phthalate (DBP) on the methylation and expression level of p53 gene in the liver of Wistar rats].

    by Katarzyna Urbanek-Olejnik, Monika Liszewska, Grazyna Kostka

    Currently, nongenotoxic carcinogens-induced changes in DNA methylation profile are considered as mechanism of their toxicity, including carcinogenic action. The aim of the study was to determine the effect of dibutyl phthalate (DBP) on the methylation levels of the p53 promoter region, as well as mRNA and protein level of this gene. Male Wistar rats received DBP in one, three or fourteen daily oral doses (at 24-h intervals) of 1800 mg/kg b.w. x day(-1). The methylation level of c-myc gene was determined by PCR-based methylation sensitive restriction enzyme analysis (MSRA). The expression of gene was assessed by Real-Time PCR (at mRNA level) and Western blot (at protein level) analysis. There was observed the hypermethylation of p53 promoter region after short (1 day) exposure of the animals to DBP. No correlation was found between mRNA expression and methylation level of p53 gene. The present study showed decreased level of p53 protein, during the whole period of study. No direct correlation was observed between the methylation and expression level of p53. The decreased protein level might be a consequence of the repressive effect of c-myc, which was involved in signal transduction pathways, the same as p53 protein.


    • 1 January 2011
      • Vol. 62  (2) , 127-36

    [Cumulative exposure to pesticide residues in food].

    by Grazyna Kostka, Katarzyna Urbanek-Olejnik, Monika Liszewska

    The results of food monitoring studies indicate that humans are constantly exposed to residues ofplant protection products (pesticides) in marketed food products. Hence, assessment of the risk to consumers associated with the consumption of products containing residues of the active substances of pesticides is a key stage in both the registration of pesticides and official control of foodstuffs. However there are frequent cases of exposure not only to individual active substances but also to mixtures of pesticide residues. These levels are usually low, below of effective action, and interaction such as synergism orpotentiation is not expected to occur At the same time, literature data indicate that for mixtures sharing a common MOA (Mode of Action/Mechanism of Action), the probability of additive effects is high, even after adjusting for the low levels of the mixed pesticide residues present. Accordingly, health risk assessment for consumers exposed to such mixtures (cumulative/aggregate risk) has become an issue of topical importance. EU-level initiatives regarding the development of appropriate methodology for the estimation of cumulative/aggregate risk have brought about considerable progress in this area. The article discusses various aspects of estimation of cumulative risk for consumers associated with exposure to mixtures of pesticide residues in food.

  • Di-butyl phthalate—induced hypomethylation of the c-myc gene in rat liver

    by Grażyna Kostka, Katarzyna Urbanek-Olejnik, Bożena Wiadrowska

    Peroxisome proliferators (PPs)-induced DNA hypomethylation has been proposed as a mechanism of their toxicity, including carcinogenic action. The effect of di-butyl phthalate (DBP), a known peroxisome proliferators, on the methylation level of the c-myc promoter region in rat liver was studied. Changes in the methylation status of the c-myc gene were correlated with changes in DNA synthesis, DNA methyltransferase (DNMTs) activity and liver weight. Male Wistar rats received DBP in one, three or fourteen daily oral doses of 1800 mg/kg body weight (b.w.) × day—1 (this dose is close to the dose that increases the numbers of peroxisomes in male Wistar rats). We have demonstrated that DBP decreased the methylation of the c-myc gene. Cytosine hypomethylation in the analyzed CpG sites of the c-myc gene promoter occurred during the whole period of study, although after 14 doses of DBP the difference from control was only on the borderline of significance (p = 0.066). An increase in DNA synthesis was only observed after 24 hours of treatment with DBP, and it preceded liver growth. We hypothesize that DBP-induced demethylation of the c-myc gene was an active mechanism, not associated with DNMTs activity and DNA replication.


    • 1 January 2010
      • Vol. 61  (2) , 119-27

    [Toxicogenomics in hazard assessment of chemicals].

    by Grazyna Kostka, Monika Liszewska, Katarzyna Urbanek-Olejnik

    Recent changes in the European legislation of chemicals suggest an urgent need for introduction of novel, alternative methods for testing chemical substances. Such possibility is offered by toxicogenomics--a scientific discipline combining knowledge from the field of toxicology, i.e., a science investigating the properties of toxic agents and the negative effects these agents exert on health and environment, with genomics, i.e., a science investigating the structure and function of genomes. New research strategies within the field of toxicology (transcriptomics, proteomics, metabolomics) offer conditions to assess the hazards associated with the effects of chemicals with both established and suspected toxic potentials.


    • 1 January 2008
      • Vol. 59  (4) , 389-96

    [Violations of mrls for pesticide residues in food reported for risk assessment according to RASFF procedures in Poland].

    by Jan Krzysztof Ludwicki, Grazyna Kostka

    The results of risk assessment to evaluate the potential risk from food products of plant origin in cases of violations of maximum residue limits for pesticides (MRLs) have been presented. According to the rules set in the RASFF any violation of legally established limit should undergo the risk assessment to allow quantitative approach in hazard evaluation for consumers. The basis of risk assessment have been presented as tool for risk management in the official food control. In case of MRLs violations the risk was assessed for general population as well as for small children as the most vulnerable part of the population. Since beginning of the RASFF in Poland--since mid of 2003 till the end of 2007--148 notifications of MRLs violations underwent risk assessment procedures. This means 2.5% of the overall number of analyzed samples. However, as much as 0.39% of the samples taken for analysis posed a real, considerable risk for consumers health, and the small children seem to be the group at greatest risk.

    • 1 January 2008
      • Vol. 59  (4) , 455-65

    [Phenobarbital-induced hypermethylation of the p53 promoter region in the liver of Wistar rats].

    by Grazyna Kostka, Katarzyna Urbanek-Olejnik, Bozena Wiadrowska, Robert Bańkowski

    Non-genotoxic carcinogens (NGCs)-induced changes of DNA methylation has been proposed as a mechanism of their toxicity, including carcinogenic action. The effect of phenobarbital (PB), a rodent liver carcinogen on the methylation level of the p53 promoter region in rat liver was studied. Changes in the methylation status of the p53 gene were correlated with changes in DNA synthesis, DNA methyltransferase (DNMTs) activity and liver weight. Male Wistar rats received PB in one, three or fourteen daily oral doses of 92.8 mg/kg b.w. x day(-1). We have demonstrated that PB increased the methylation of the p53 gene. Cytosine hypermethylation in the analyzed CpG sites of the p53 gene promoter occurred during the whole period of study. However, an increase in DNA synthesis was only observed after 1 and 3 days of treatment with PB and it preceded liver growth. Treatment of rats with PB for 1 and 3 days also produced an increase in nuclear DNMTs activity. After prolonged administration (14 days), no changes in DNMTs activity nor DNA synthesis were observed. It is proposed that PB-induced de novo methylation of the p53 gene was not associated with DNMTs activity.

  • The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver

    by Grażyna Kostka, Katarzyna Urbanek, Jan K. Ludwicki


    • 1 January 2002
      • Vol. 53  (1) , 1-9

    [Effect of diclofop on the activity of some drug-metabolizing enzymes in the liver of male Wistar rats].

    by Danuta Palut, Grazyna Kostka, Bozena Wiadrowska, Robert Bańkowski

    The study was designed to determine whether diclofop, introduced to environment as herbicide, would exert properties of chemical inducers of rat liver monooxygenase system related to CYP1A and CYP2B isozymes. For this purpose, the effect of diclofop on 7-etoxyresorufin O-dealkylase and p-nitroanisole O-demethylase activities specific for CYP1A as well as on CYP2B mediated 7-pentoxyresorufin O-dealkylase activity was studied in male Wistar rats. This biochemical method permits to determine whether tested compound belongs to one of two main types of chemical inducers. Diclofop was dosed by gavage for 4 days at 0; 5.6, 11.2 and 56 mg/kg b.w. per day. Treatment of rats with diclofop resulted in significant increase in relative liver weight (RLW), to 19% and 31% above the control, respectively. Diclofop administered at the dose of 11.2 and 56 mg/kg b.w. per day induced a 3-fold (p < 0.001) and a 5-fold (p < 0.001) increase in the metabolism of 7-pentoxyresorufin (CYP2B-mediated reaction), respectively. No effect level for CYP2B induction was 5.6 mg/kg b.w per day. However, diclofop induced only slight increase in 7-etoxyresorufin O-dealkylase and did not show any effect on p-nitroanisole O-demethylase activity (CYP1A-mediated reactions). The results revealed that diclofop not show the ability to induce CYP1A and moreover it was weak inducer of CYP2B isozymes in the liver of male Wistar rats. Diclofop was also examined for its ability to affect the activity of phenol UDP-glucuronosyltransferase in rat liver. The results suggest that diclofop suppressed phenol form of UDP-glucuronosyltransferase activity. The isozyme activity decreased by 50% and 35% at the dose of 11.2 and 56 mg/kg b.w. per day, respectively. It should be noted that this form of enzyme inactivates during II phase of biotransformation most chemical carcinogens and other xenobiotics.